References 1. Adolph, KW; Long, GL; Winfield, S; Ginns, EI; Bornstein, P. Structure and organization of the human thrombospondin 3 gene (THBS3). Genomics. 1995;27:329–336. [PubMed]2. Baker, E; Guo, X-H; Orsborn, AM; Sutherland, GR; Callen, DF; Hopewood, JJ; Morris, CP. The Morquio A syndrome (mucopolysaccharidosis IVA) gene maps to 16q24.3. Am J Hum Gene. 1993;52:96–98. 3. Ballo, R; Briggs, MD; Cohn, DH; Knowlton, RG; Beighton, PH; Ramesar, RS. Multiple epiphyseal dysplasia, Ribbing type: A novel point mutation in the COMP gene in a South African family. Amer J Med Genet. 1997;68:396–400. [PubMed]4. Bender, W. Homeotic gene products as growth factors. Cell. 1985;43:559–560. [PubMed]5. Breur, GJ; Zebre, CA; Slocombe, RF; Padgett, GA; Braden, TD. Clinical, radiographic, pathologic, and genetic features of osteochondrodysplasia in Scottish deerhounds. J Am Veter Med Assn. 1989;195:606–612. 6. Breur, GJ; Farnum, CE; Padgett, GA; Wilsman, NJ. Cellular basis of decreased rate of longitudinal growth of bone in pseudoachondroplastic dogs. J Bone and Joint Surg. 1992;74-A:516–528. [PubMed]7. Briggs, MD; Rasmussen, IM; Weber, JL; Yuen, J; Reinker, K; Garber, AP; Rimoin, DL; Cohn, DH. Genetic linkage of mild pseudoachondroplasia (PSACH) to markers in the pericentromeric region of chromosome 19. Genomics. 1993;18:656–660. [PubMed]8. Briggs, MD; Choi, H; Warman, ML; Loughlin, JA; Wordsworth, P; Sykes, BC; Irven, CM; Smith, M; Wynne-Davies, R; Lipson, MH; Biesecher, LC; Garber, AP; Lachman, R; Olsen, BR; Rimoin, DL; Cohn, DH. Genetic mapping of a locus for multiple epiphyseal dysplasia (EDM2) to a region of chromosome 1 containing a type IX collagen gene. Am J Hum Genet. 1994;55:678–684. [PubMed]9. Briggs, MD; Hoffman, SMG; King, LM; Olsen, AS; Mohrenweiser, H; Leroy, JG; Mortier, GR; Rimoin, DL; Lachman, RS; Gaines, ES; Cekleniak, JA; Knowlton, RG; Cohn, DH. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nature Genet. 1995;10:330–336. [PubMed]10. Briggs, MD; Mortier, GR; Cole, WG; King, LM; Golik, SS; Bonaventure, J; Nuytinck, L; De Paepe, A; Leroy, JG; Biesecker, L; Lipson, M; Wilcox, WR; Lachman, RS; Rimoin, DL; Knowlton, RG; Cohn, DH. Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet. 1998;62:311–319. [PubMed]11. Cooper, RR; Ponseti, IV; Maynard, JA. Pseudoachondroplastic dwarfism. A rough-surfaced endoplasmic reticulum storage disorder. J Bone and Joint Surg. 1973;55-A:475–484. [PubMed]12. Chen, H; Aeschlimann, D; Nowlen, J; Mosher, DF. Expression and initial characterization of recombinant mouse thrombospondin 1 and thrombospondin 3. FEBS Lett. 1996;387:36–41. [PubMed]13. Chen, LL; Stevens, JW; Martin, JA; Hecht, JT; Ver tel, BM. A cell model for pseudoachondroplasia and COMP. Mol Biol Cell. 1998. 14. Deere, M; Blantin, SH; Scott, CI; Langer, LO; Pauli, RM; Hecht, JT. Genetic heterogeneity in multiple epiphyseal dysplasia. Am J Hum Genet. 1995;56:698–704. [PubMed]15. Deere, M; Sanford, T; Ferguson, HL; Daniels, K; Hecht, JT. Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia. Am J Med Genet. 1998;80:510–513. [PubMed]16. Délot, E; Brodie, SG; King, LM; Wilcox, WR; Cohn, DH. Physiological and pathological secretion of cartilage oligomeric matrix protein by cells in culture. J Biol Chem. 1998;273:26692–26697. [PubMed]17. Délot, E; King, LM; Briggs, MD; Wilcox, WR; Cohn, DH. Trinucleotide expansion mutations in the cartilage oligomeric matrix protein (COMP) gene. Hum Mol Genet. 1999;8:123–128. [PubMed]18. Di Cesare, PE; Möglin, M; Carlson, CS; Pasumarti, S; Paulsson, M. Cartilage oligomeric matrix protein: Isolation and characterization from human articular cartilage. J Orthop Res. 1995;13:422–428. [PubMed]19. Efimov, VP; Lustig, A; Engel, J. The thrombospondin-like chains of cartilage oligomeric matrix protein are assembled by a five-strand (-helical bundle between residues 20 and 83. FEBS Letters. 1994;341:54–58. [PubMed]20. Ekman, S; Reinholt, FP; Hultenby, K; Heinegård, D. Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in porcine growth cartilage. Calci Tissue Int. 1997;60:547–553. 21. Ferguson, HL; Deere, M; Evans, R; Rotta, J; Hal, JG; Hecht, JT. Mosaicism in pseudoachondroplasia. Am J Med Genet. 1997;70:287–291. [PubMed]22. Hall, JG; Dorst, JP. Pseudoachondroplastic SED, recessive Maroteaux-Lamy type. Birth Defects Orig Art Ser. 1969;V(4):254–259. 23. Hall, JG; Dorst, JP; Rotta, J; McKusick, VA. Gonadal mosaicism in pseudoachondroplasia. Am J Med Genet. 1987;28:143–151. [PubMed]24. Hecht, JT; Francomano, CA; Briggs, MD; Deere, M; Conner, B; Horton, WA; Warman, M; Cohn, DH; Blanton, SH. Linkage of typical pseudoachondroplasia to chromosome 19. Genomics. 1993;18:661–666. [PubMed]25. Hech, JT; Nelson, LD; Crowder, E; Wang, Y; Elder, FFB; Harrison, WR; Francomano, CA; Prange, CK; Lennon, GG; Deere, M; Lawler, J. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nature Genet. 1995;10:325–329. [PubMed]26. Hecht, JT; Deere, M; Putnam, E; Cole, W; Vertel, B; Chen, H; Lawler, J. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues. Matrix Biol. 1998;17:269–278. [PubMed]27. Ikegawa, S; Ohashi, H; Nishmura, G; Kim, KC; Sannohe, A; Kimizuka, M; Fukushima, Y; Nagai, T; Nakamura, Y. Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia. Hum Genet. 1998;103:633–638. [PubMed]28. Incardona, F; Lawler, J; Cataldo, D; Panet, A; Legrand, Y; Foidart, JM; Legrand, C. Heparin-binding domain, type 1 and type 2 repeats of thrombospondin mediate its interaction with human breast cancer cells. J Cell Biochem. 1996;15:431–442. [PubMed]29. Jaffe, E; Bornstein, P; Disteche, CM. Mapping the thrombospondin gene to human chromosome 15 and mouse chromosome 2 by in situ hybridization. Genomics. 1990;7:123–126. [PubMed]30. Kim, HW; Martin, JA; Schroeder, AC; Kurriger, GL; Maynard, JA; Stevens, JW. PSACH-linked COMP mutation alters chondrosarcoma ECM formation. Trans Orthop Res Soc. 1999;24:430. 31. Knowlton, RG; Cekleniak, JA; Cohn, DH; Briggs, MD; Hoffman, SM; Brandriff, BF; Olsen, AS. High-resolution genetic and physical mapping of multiple epiphyseal dysplasia and pseudoachondroplasia mutations at chromosome 19p13.1-p12. Genomics. 1995;28:513–519. [PubMed]32. Kretsinger, RH. Crystallographic studies of calmodulin and homologs. Ann NY Acad Sci. 1980;356:1–19. [PubMed]33. LaBell, TL; McGookey-Milewicz, DJ; Disteche, CM; Byers, PH. Thrombospondin II: Partial cDNA sequence, chromosome location, and expression of a second member of the thrombospodin gene family in humans. Genomics. 1992;12:421–429. [PubMed]34. Laherty, CD; O'Rourke, K; Wolf, FW. Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. J Biol Chem. 1992;267:24921–24924. [PubMed]35. Lawler, J; Simons, ER. Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. J Biol Chem. 1983;258:12098–12101. [PubMed]36. Lawler, J; Derick, LH; Connolly, JE; Chen, JH; Chao, FC. The structure of human platelet thrombospondin. J Biol Chem. 1985;260:3762–3772. [PubMed]37. Lawler, J; Hynes, RO. The structure of human thrombospondin, an adhesion glycoprotein with multiple calcium-binding sites and homologies with several proteins. J Cell Biol. 1986;103:1635–1648. [PubMed]38. Lawler, J; Weinstein, R; Hynes, RO. Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol. 1988;107:2351–2361. [PubMed]39. Lawler, J; McHenry, K; Duquette, M; Derick, L. Characterization of human thrombospondin- 4. J Biol Chem. 1995;270:2809–2814. [PubMed]40. Lindseth, RE; Danigelis, JA; Murray, DG; Wray, JB. Spondylo-epiphyseal dysplasia (Pseudoachondroplastic type). Amer J Dis Child. 1967;13:721–726. [PubMed]41. Loughlin, J; Irven, C; Mustafa, Z; Briggs, MD; Carr, A; Lynch, A-A; Knowlton, RG; Cohn, DH; Sykes, B. Identification of five novel mutations in cartilage oligomeric matrix protein gene in pseudoachondroplasia and multiple epiphyseal dysplasia. Human Mutat Suppl. 1998;1:S10–S17. 42. Maddox, BK; Keene, DR; Sakai, LY; Charbonneau, NL; Morris, NP; Ridgway, CC; Boswell, BA; Sussman, MD; Horton, WA; Bachinger, HP; Hecht, JT. The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia. J Biol Chem. 1997;272:30993–30997. [PubMed]43. Malashkevich, VN; Kammerer, RA; Efmov, VP; Schulthess, T; Engel, J. The crystal structure of a five-stranded coiled coil in COMP: A proteotype in channel. Science. 1996;274:761–765. [PubMed]44. Maroteaux, P; Lamy, M. Les formes pseudoachondroplastiques des dysplasies spondyloepiphysaires. Presse Med. 1959;67:383–386. [PubMed]45. Maynard, JA; Cooper, RR; Ponseti, IV. A unique rough surface endoplasmic reticulum inclusion in pseudoachondroplasia. Lab Invest. 1972;26:40–44. [PubMed]46. McKeand, J; Rotta, J; Hecht, JT. Natural history study of pseudoachondroplasia. Am J Med Genet. 1996;63:406–410. [PubMed]47. Mitas, M. Trinucleotide repeats associated with human diseases. Nucleic Acids Res. 1997;12:2245–2253. [PubMed]48. Misenheimer, TM; Mosher, DF. Calcium ion binding to thrombospondin 1. J Biol Chem. 1995;270:1729–1733. [PubMed]49. Mörgelin, M; Heinegård, D; Enge, J; Paulsson, M. Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-arm structure. J Biol Chem. 1992;267:6137–6141. [PubMed]50. Muragaki, Y; Mariman, ECM; van Berrsum, SEC; Perala, M; van Mourik, JBA; Warman, ML; Olsen, BR; Hamel, BCJ. A mutation in the gene encoding the alpha-2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2). Nat Genet. 1996;12:103–105. [PubMed]51. Newton, G; Weremowicz, S; Morton, CC; Copeland, NG; Gilbert, DJ; Jenkins, NA; Lawler, J. Characterization of human and mouse cartilage oligomeric matrix protein. Genomics. 1994;24:435–439. [PubMed]52. Oehlmann, R; Summerville, GP; Yeh, G; Weaver, EJ; Jimenez, SA; Knowlton, RG. Genetic linkage mapping of multiple epiphyseal dysplasia to the pericentromeric region of chromosome 19. Am J Hum Genet. 1994;54:3–10. [PubMed]53. Oldberg, Å; Antonsson, P; Lindbloom, K; Heinegård, D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem. 1992;267:22346–22350. [PubMed]54. O'Rourke, KM; Laherty, CD; Dixit, VM. Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. J Biol Chem. 1992;267:24921–24924. [PubMed]55. Qabar, A; Derick, L; Lawler, J; Dixit, V. Thrombospondin 3 is a pentameric molecule held together by interchain disulfide linkage involving two cysteine residues. J Biol Chem. 1995;270:12725–12729. [PubMed]56. Sottile, J; Seleue, J; Mosher, DF. Synthesis of truncated amino-terminal trimers of thrombospondin. Biochemistry. 1991;30:6556–6562. [PubMed]57. Shiang, R; Thompson, LM; Zhu, Y-Z; Church, DM; Fielder, TJ; Bocian, M; Winokur, ST; Wasmuth, JJ. Mutations in the transmebrane domain of FGFR3 cause the most common genetic from of dwarfism, achondroplasia. Cell. 1994;78:335–342. [PubMed]58. Shen, Z; Heinegård, D; Sommarin, Y. Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development. Matrix Biology. 1995;14:773–781. [PubMed]59. Stanescu, V; Maroteaux, P; Stanescu, R. The biochemical defect of pseudoachondroplasia. Europ J Pediat. 1982;138:221–225. [PubMed]60. Stanescu, V; Stanescu, R; Marteaux, P. Pathogenic mechanisms in osteochondro-dysplasias. J Bone and Joint Surg. 1984;66-A:817–836. [PubMed]61. Stanescu, R; Stanescu, V; Muriel, M-P; Maroteaux, P. Multiple epiphyseal dysplasia, Fairbank type: Morphologic and biochemical study of cartilage. Am J Med Genet. 1993;45:501–507. [PubMed]62. Stevens, JW; Rapp, TB; Martin, JA; Maynard, JA; Vertel, BA; Hecht, JT. Stable transfection of chondrocytes with mutant human COMP. Trans Orthop Res Soc. 1998;23:103. 63. Susic, S; McGrory, J; Ahier, J; Cole, WG. Multiple epiphyseal dysplasia and pseudoachondroplasia due to novel mutation in the calmodulin-like repeats of cartilage oligomeric matrix protein. Clin Genet. 1997;51:219–224. [PubMed]64. Susic, S; Ahier, J; Cole, WG. Pseudoachondroplasia due to the substitution of the highly conserved Asp482 by Gly in the seventh calmodulin-like repeat of cartilage oligomeric matrix protein. Hum Mutat Suppl. 1998;1:S125–S127. 65. Vos, HL; Devarayalu, S; de Vries, Y; Bornstein, P. Thrombospondin 3 (Thbs3), a new member of the thrombospondin gene family. J Biol Chem. 1992;267:12192–12196. [PubMed]66. Wynne-Davies, R; Hall, CM; Young, ID. Pseudoachondroplasia: Clinical diagnosis at different ages and comparison of autosomal dominant and recessive types. A review of 32 patients (26 kindred). J Med Genet. 1986;23:425–434. [PubMed]67. Yu, A; Dill, J; Mitas, M. The purine-rich trinucleotide repeat sequences d(CAG)15 and d(GAC)15 form hairpins. Nucleic Acids Res. 1995;23:4055–4057. [PubMed]68. Zaia, J; Boynton, RE; McIntosh, A; Marshak, DR; Olsson, H; Heinegård, D; Barry, FP. Post-translational modifications in cartilage oligomeric matrix protein. Characterization of the N-linked oligosaccharides by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J Biol Chem. 1997;272:14120–14126. [PubMed] |